𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome

✍ Scribed by Beckel-Mitchener, Andrea ;Greenough, William T.


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
116 KB
Volume
10
Category
Article
ISSN
1080-4013

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Fragile X syndrome (FXS) is characterized by a pattern of morphological, functional, and molecular characteristics with, in at least some cases, apparent relationships among phenotypic features at different levels. Gross morphology differences in the sizes of some human brain regions are accompanied by fine structural alterations in the shapes and in the numbers of dendritic spines in both humans and the knockout mouse model. The excess number of spines, their immature appearance, and the impaired withdrawal of inappropriately oriented dendrites in FXS or the mouse model suggest impairment of neuronal maturation, including dendritic and spine pruning. It is not clear how these differences arise, although regionally or globally impaired translation of the mRNAs that interact with the Fmr1 protein product, FMRP, in the vicinity of the synapse, including genes involved in synapse development and plasticity and dendritic retraction, is certainly plausible. FMRP binds mRNA and may be involved in both transport and translation of the mRNAs it binds. The mRNAs it binds belong to multiple functional classes, apparently indicating that FMRP may impact multiple cellular processes. In one example, the glucocorticoid receptor, whose mRNA binds FMRP, regulates the stress‐sensitive glucocorticosteroids. Both human FXS and the mouse model exhibit a protracted elevation in glucocorticosteroids after stress. Possible relationships of other genes to morphological and functional characteristics of FXS are also discussed. MRDD Research Reviews 2004;10:53–59. Β© 2004 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Genotype, molecular phenotype, and cogni
✍ Kaufmann, Walter E.; Abrams, Michael T.; Chen, Wilma; Reiss, Allan L. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 42 KB πŸ‘ 2 views

The study of the neurobehavioral consequences of mutations of FMR1, the gene responsible for fragile X syndrome (FraX), has been based largely on correlations between mutation patterns and cognitive profile. Following the characterization of FMRP, the FMR1 gene product, preliminary correlations betw

Molecular studies of the fragile X syndr
✍ Knight, Samantha J. L. ;Hirst, Mark C. ;Roche, Anya ;Christodoulou, Zoe ;Huson, πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 522 KB
Functional status of men with the fragil
✍ Angela G. Brega; Ann Reynolds; Rachael E. Bennett; Maureen A. Leehey; Lanee S. B πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

## Abstract ## Background Fragile X‐associated tremor/ataxia syndrome (FXTAS), which occurs in some premutation carriers of the fragile X mental retardation 1 (__FMR1__) gene, is a neurodegenerative disorder characterized by action tremor, gait ataxia, and impaired executive cognitive functioning.

Deletion of 8.5 Mb, including theFMR1 ge
✍ Parvari, R.; Mumm, S.; Galil, A.; Manor, E.; Bar-David, Y.; Carmi, R. πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 2 views

A four-year-old boy with severe psychomotor retardation, facial appearance consistent with the fragile X syndrome, hypotonia, and overgrowth was found to have a deletion including the fragile X gene (FMR1). The breakpoints of the deletion were established between CDR1 and sWXD2905 (approximately 200